V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20182203 | 20088136 | 1.7 | 59 | 03 | null | 2020-02-26 | IBRUTINIB | 02 | N | DOCETAXEL | 101734506 |
| 20182235 | 20088137 | 1.6 | 71.9 | Adjuvant (A) | 2018-03-17 | 2018-03-24 | Bevacizumab + Oxaliplatin +MdG | 02 | N | CAPITAL TRIAL | 101488729 |
| 20182337 | 20088139 | 1.74 | 67 | null | 2019-12-23 | 2020-01-11 | POMALIDOMIDE | 02 | N | IRINOTECAN + MDG + PANITUMUMAB | 100710639 |
| 20182397 | 20088140 | 1.72 | 68.2 | null | 2019-07-20 | 2019-08-17 | Hydroxycarbamide | N | N | CYCLOPHOSPHAMIDE | 100065609 |
| 20182493 | 20088141 | 1.74 | 88.1 | Palliative (P) | 2017-02-02 | 2017-02-02 | ECarboX | 01 | N | FLUOROURACIL + RT | 100817564 |
| 20182517 | 20088142 | 1.57 | 69.6 | Curative (C) | 2017-04-25 | 2017-04-28 | Panitumumab | 02 | N | GEMCITABINE + PACLITAXEL | 100203415 |
| 20182535 | 20088143 | 1.52 | 85.8 | Curative (C) | null | 2020-02-29 | CARBOPLATIN + FLUOROURACIL | null | N | ESPAC TRIAL | 100135184 |
| 20182568 | 20088144 | 1.68 | 55.6 | null | 2018-02-22 | 2018-02-22 | null | 02 | N | PACLITAXEL | 101562122 |
| 20182777 | 20088145 | 1.83 | 79.35 | Palliative (P) | 2020-01-27 | 2020-01-28 | Capecitabine+Cisplatin+Streptozocin | 02 | Y | NIVOLUMAB | 100892704 |
| 20182899 | 20088147 | 1.65 | 52.65 | Palliative (P) | 2019-09-05 | 2019-09-16 | Sunitinib | 02 | N | PLATFORM TRIAL | 101178269 |
| 20183014 | 20088148 | 1.78 | 101 | 03 | 2019-01-03 | 2019-01-03 | FCarboSt | 02 | N | ACELARATE TRIAL | 100735067 |
| 20183119 | 20088150 | 1.76 | 94.7 | null | 2018-06-20 | 2018-06-27 | OXALIPLATIN | 01 | N | CAPECITABINE + STREPTOZOCIN | 101296146 |
| 20183284 | 20088151 | 1.68 | 63 | Palliative (P) | 2016-04-06 | 2016-04-23 | MCX | 2 | N | SCOPE2 TRIAL | 100572234 |
| 20183306 | 20088152 | null | null | 03 | 2017-07-25 | 2017-07-29 | Hydroxycarbamide | 02 | N | HYDROXYCARBAMIDE | 100379481 |
| 20183410 | 20088153 | 1.6 | 67 | Adjuvant (A) | 2018-01-11 | 2018-01-12 | Capital Trial | 02 | N | SUNITINIB | 100837195 |
| 20183463 | 20088154 | 1.7 | 74 | null | 2016-08-10 | 2016-09-05 | RALTITREXED | 02 | Y | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101746146 |
| 20183556 | 20088156 | 1.55 | 75 | null | 2019-03-22 | 2019-04-04 | SCOPE 2 TRIAL | 02 | N | ABVD | 100595571 |
| 20183636 | 20088157 | 1.6 | 56.5 | 03 | 2016-08-18 | 2016-08-22 | IPILIMUMAB + NIVOLUMAB | 01 | N | ABIRATERONE | 101658752 |
| 20183764 | 20088158 | null | 80 | Palliative (P) | 2018-02-16 | 2018-02-21 | PLATO Trials | 02 | N | PLATO TRIAL | 100851702 |
| 20183881 | 20088159 | 1.65 | 173 | Curative (C) | 2018-09-11 | 2018-09-29 | ARISTOTLE TRIAL | 02 | N | BORTEZOMIB | 101069314 |
| 20183907 | 20088160 | 1.6 | 72.9 | Palliative (P) | 2019-12-10 | 2019-12-11 | DABRAFENIB + TRAMETINIB | 02 | N | CYCLOPHOSPHAMIDE | 101672692 |
| 20183944 | 20088161 | 1.78 | 67.9 | Palliative (P) | 2022-01-16 | 2022-01-31 | NIVOLUMAB | 02 | N | NIVOLUMAB | 101521617 |
| 20184014 | 20088162 | 1.79 | 100 | Palliative (P) | 2018-06-13 | 2018-06-14 | BCG Intravesical | 01 | N | BACILLUS CALMETTE-GUERIN | 101513318 |
| 20184094 | 20088163 | 1.78 | 74 | Palliative (P) | 2018-11-02 | 2018-11-16 | Bortezomib + CYCLOPHOSPHAMIDE | 01 | N | CAPECITABINE + OXALIPLATIN + TRASTUZUMAB | 101007005 |
| 20184193 | 20088164 | 1.79 | 54 | Adjuvant (A) | 2018-03-22 | 2018-03-22 | CHOP R - 21 days | 02 | N | CISPLATIN + VINORELBINE | 101389859 |
| 20184308 | 20088165 | 1.55 | 95.4 | 03 | 2019-09-12 | 2019-10-22 | Paclitaxel 7 day | Y | null | OXALIPLATIN | 100669532 |
| 20184496 | 20088167 | 1.6 | 48.7 | Palliative (P) | 2017-01-29 | 2017-02-01 | Rituximab | N | N | CISPLATIN + FLUOROURACIL + RT | 100023712 |
| 20184560 | 20088168 | 1.69 | null | Palliative (P) | null | 2018-09-20 | CHOP R | 02 | N | EPIRUBICIN + FLUOROURACIL + OXALIPLATIN | 101540921 |
| 20184701 | 20088169 | 1.79 | 62.2 | 03 | 2019-11-27 | 2019-12-09 | EOF | 02 | N | HYDROXYCARBAMIDE | 101683991 |
| 20184708 | 20088170 | 1.6 | 69.7 | Palliative (P) | 2018-05-19 | 2018-06-06 | NEO-AEGIS TRIAL | 02 | N | RITUXIMAB | 100844082 |
| 20184820 | 20088171 | null | 63.8 | 03 | 2016-04-15 | 2016-04-16 | MPV (cycle 1-4) | 02 | N | IRINOTECAN + MDG + PANITUMUMAB | 100129984 |
| 20184873 | 20088172 | 1.73 | 90.4 | null | 2019-06-05 | 2019-06-13 | SCOPE 2 TRIAL | 02 | N | CARBOPLATIN + DOXORUBICIN + MITOMYCIN | 100684586 |
| 20184976 | 20088173 | 1.83 | 90.4 | 03 | 2018-02-21 | 2018-03-29 | RUXOLITINIB | N | N | MITOMYCIN | 100602943 |
| 20185051 | 20088174 | 1.63 | 83 | Adjuvant (A) | 2016-10-03 | 2016-10-03 | Ipilimumab | 02 | N | CAPECITABINE + CISPLATIN + STREPTOZOCIN | 101307877 |
| 20185195 | 20088175 | 1.66 | 60.1 | Palliative (P) | 2019-04-02 | 2019-04-22 | Bortezomib + CYCLOPHOSPHAMIDE | N | N | CISPLATIN + VINORELBINE | 100207623 |
| 20185506 | 20088176 | 1.6 | 48.5 | Palliative (P) | 2018-01-27 | 2018-02-03 | Cyclophosphamide + Docetaxel | 02 | N | AZACITIDINE | 101528267 |
| 20185523 | 20088177 | 1.71 | 65 | null | 2017-03-27 | 2017-04-03 | HEP SIOPEL 6 Cisplatin | 02 | N | CARBOPLATIN + EPIRUBICIN | 101382889 |
| 20185668 | 20088178 | 1.65 | 118.2 | Palliative (P) | 2017-08-13 | 2017-08-15 | EVEROLIMUS | 02 | Y | SCOPE2 TRIAL | 100764490 |
| 20185965 | 20088179 | 1.7 | null | Adjuvant (A) | 2019-06-15 | 2019-06-15 | Bortezomib + CYCLOPHOSPHAMIDE | Y | N | PHITT D SIOPEL-4 (A1, A2, A3) | 101692704 |
| 20186177 | 20088181 | null | null | null | 2018-11-09 | 2018-11-12 | GEMCARBO | 01 | N | PACLITAXEL | 100061844 |
| 20186215 | 20088182 | 1.71 | 93.9 | Palliative (P) | 2018-05-25 | 2018-05-25 | EC | N | N | MPV | 100845002 |
| 20186229 | 20088183 | 1.68 | 64 | null | 2016-04-26 | 2016-05-09 | CISPLATIN + FLUOROURACIL + Trastuzumab | 02 | N | TEMOZOLOMIDE + RT | 100923727 |
| 20186389 | 20088184 | 1.6 | 59.3 | Palliative (P) | null | 2019-07-23 | Fluorouracil + Folinic + RT Bossett | N | N | ARISTOTLE TRIAL | 101404371 |
| 20187013 | 20088185 | 1.75 | 66.7 | null | 2019-10-21 | 2019-11-04 | null | 02 | N | RITUXIMAB | 101856720 |
| 20187029 | 20088186 | 1.63 | 62.6 | null | 2018-08-08 | 2018-08-12 | EEF or EOF | 02 | null | OXALIPLATIN | 101274546 |
| 20187063 | 20088187 | 1.7 | 81.8 | Palliative (P) | null | 2019-06-22 | CISPLATIN + FLUOROURACIL + Trastuzumab | N | null | IRINOTECAN | 100991051 |
| 20187070 | 20088188 | 1.67 | 41 | Palliative (P) | 2017-06-23 | 2017-06-27 | ECarboX | 02 | N | SUNITINIB | 101775934 |
| 20187184 | 20088189 | 1.68 | 96.5 | Palliative (P) | 2019-09-17 | 2019-09-17 | CAPECITABINE + CARBOPLATIN + Trastuzumab | 02 | N | CAPITAL TRIAL | 101518294 |
| 20187251 | 20088190 | null | 55.5 | Palliative (P) | null | 2018-04-22 | Hydroxycarbamide | N | N | CISPLATIN + FLUOROURACIL + RT | 101844547 |
| 20187295 | 20088191 | 1.45 | 52.6 | Adjuvant (A) | 2017-06-04 | 2017-06-11 | CAPE + OXALIPLATIN + TRASTUZUMAB | 02 | N | FCIST | 101287487 |